Catalyst Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
CPRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
355 Alhambra Circle, Suite 801, Coral Gables, FL

Insiders trading volume in the past year

Catalyst Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Patrick J. Mcenany Director, Chairman of Board of Directors $96.3M -$5.22M -5.14% Dec 1, 2025
Steve Miller Chief Op. & Scientific Officer $26.3M -$3.43M -11.5% Nov 20, 2025
Donald A. Denkhaus Director $11M Nov 20, 2025
Richard J. Daly President and CEO, Director $10.1M +$1.27M +14.3% Nov 20, 2025
David S. Tierney Director $8.62M -$525K -5.74% Nov 20, 2025
Brian Elsbernd Chief Compliance/Legal Officer $7.42M -$2.14M -22.3% Nov 20, 2025
Gary Ingenito Chief Med. & Reg. Officer $3.9M -$10.7M -73.2% May 13, 2025
Preethi Sundaram Chief Strategy Officer $2.49M -$104K -3.99% Nov 20, 2025
Jeffrey Del Chief Commercial Officer $2.18M -$953K -30.4% Nov 26, 2025
Charles B. O'Keeffe Director $2.11M Feb 14, 2025
Michael W. Kalb Executive Vice President & CFO $2.09M Nov 20, 2025
Alicia Grande VP, Treasurer and CFO $1.4M Dec 27, 2023
Molly Harper Director $450K Nov 20, 2025
Tamar Thompson Director $445K Nov 20, 2025
Philip H. Coelho Director $232K May 4, 2023
Daniel J. Curran Director $0 Nov 20, 2025
William T. Andrews Chief Medical Officer $0 Nov 20, 2025
Gregg Russo Chief HR Officer $0 Nov 20, 2025

Recent Insider Transactions by Companies or Individuals for Catalyst Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.